NephroNet is an organization dedicated to providing resources to patients, practicing clinicians, and all individuals that are concerned with improving the care of patients with kidney disease. For patients, our goal is to be an educational resource that provides practical information to patients and their families. We endorse and are motivated as an organization to improve minority participation in CKD clinical research. We believe that by improving patient education of their disease, they will be better equipped to work with their physicians.
The NephroNet membership is composed of both academic and private physicians that work closely with the National Institutes of Health (NIH), American Society Nephrology, as well as large and small healthcare companies that are motivated to treat chronic kidney disease. The NephroNet membership has experts in all areas of kidney disease and is available for consultation that will ultimately bring new therapies to the renal community.
Postponed: 2020 3rd Annual NephroNet Nephrology Update
The third annual NephroNet Nephrology Update Meeting has been postponed. Stay tuned for details to join us in September 2021, at the Four Seasons in Midtown Atlanta, Georgia.
Some of next year’s topics will include: A vigorous debate on how to treat Lupus Nephritis – Tumlin vs. Rovin, Hyperuricemic Nephropathy: A Primary Renal Vasculopathy-Pathogenesis, Diagnosis and Treatment, Transplant Pharmacology: Strategies to Minimize Long-Term Nephrotoxicity, Genetics of Transporters Defects in Hypertension and Renal Tubular Acidosis, Nephrolithiasis: Genetic Underpinnings, Detection and Management-What the Urologist Never Told You, Microbiome: Symbiotic and Pathologic Contributions to Chronic Kidney Disease (CKD) and Post Dialysis Arrhythmia & Sudden Death: Role of Rates of Potassium Clearance and Delta Ultrafiltration and “Medico Economic Update: Evolving Payments Methods for Nephrology Services: It Is As Bad As you Thought?”
Our objective is to facilitate collaboration between practicing physicians, clinical trial professionals and industry. We expect upwards of 100 MDs and NPs in attendance, and therefore have designed the session to be highly interactive, including extended Q/A sessions to maximize learnings. In addition, NephroNet will provide 10 accredited CME hours.
Mark your calendars for next September! More details are coming soon for Early Bird Registration!
2020 NephroNet Nephrology Update Webinar | FREE CME
Lupus Nephritis-Role of B Cell and Complement Altering Therapies:
A Debate on Management, The battle between the esteemed,
James Tumlin, MD, President NephroNet, Clinical Trials Consortium
Brad Rovin, MD, Division Chair Nephrology, The Ohio State University
There is no cost to the registrant. You must register to attend and to be eligible to receive the 1 CME credit. After the webinar, an evaluation form will be provided by NephroNet following the lecture for you to return to receive your 1 CME credit.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Association of Georgia through the joint providership of Southern Alliance for Physician Specialties CME and NephroNet, Inc. The Southern Alliance for Physician Specialties CME is accredited by the Medical Association of Georgia to provide continuing medical education for physicians.
The Southern Alliance for Physician Specialties CME designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
We help industry sponsors connect with lead investigators and clinical trial services in nephrology. Ready to get started? Let us help you put all the pieces together to take you from proof of concept to regulatory approval.
What Physician Attendees Said
“Best conference I’ve attended in the past 2 years.”
“Excellent Conference! Time allowed for plenty of discussions.”
“Should be held every year.”
“Spectacular conference. I’m going to tell my colleagues to attend in 2019.”
Understanding your options is the biggest hurdle. Learning more about your kidney condition is the first step.
Looking for help from a leading expert? Or want assistance writing your trial protocol? NephroNet is dedicated to provide resources to serve you and your patients.
Our team of experts provides you with the required scientific, therapeutic, and regulatory expertise to design studies for new drugs for the treatment of chronic kidney disease.